Clinical Study

Effect of Optimization of Glycaemic Control on Mannan-Binding Lectin in Type 1 Diabetes

Figure 1

Daily insulin dose (a), HbA1c (b), and plasma levels of fructosamine (c) at baseline and after 6 weeks in 52 type 1 diabetic patients changed from conventional insulin therapy to insulin pump therapy. P values refer to the change from baseline to follow-up by Student’s t-test.
(a)
(b)
(c)